What Clinical Trials Can Teach Us About the Development of More Resilient AI for Cybersecurity

Journal Article · 01 June 2021 · European Cybersecurity Journal

OSTI ID:1813216

Begoli, Edmon  ^[1]; Bridges, Robert  ^[1]; Oesch, T Sean  ^[1]; Knight, Kathryn ^[1]

---

1. Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States)

Policy-mandated, rigorously administered scientific testing is needed to provide transparency into the efficacy of artificial intelligence-–based (AI-based) cyber defense tools for consumers and to prioritize future research and development. In this work, we propose a model that is informed by our experience, urged forward by massive-scale cyberattacks, and inspired by parallel developments in the biomedical field and the unprecedentedly fast development of new vaccines to combat global pathogens.

• Research Organization: Oak Ridge National Laboratory (ORNL), Oak Ridge, TN (United States)
• Sponsoring Organization: USDOE; USDOD
• Grant/Contract Number: AC05-00OR22725
• OSTI ID: 1813216
• Journal Information: European Cybersecurity Journal, Vol. 7, Issue 1; ISSN 2450-2111
• Publisher: The Kosciuszko InstituteCopyright Statement
• Country of Publication: United States
• Language: English